Many insurance plans still do not cover GLP-1 medications for weight loss , and even when they do, prior authorization requirements can delay or deny coverage
Wegovy and Wegovy HD are the only forms FDA-approved for weight loss as injections
Even at the lowest dose of 5 mg of tirzepatide, clinical trial participants reduced their A1C levels by 2.09 percent and lost 8.5 percent of their body weight
Lilly markets tirzepatide as Mounjaro to people with Type 2 diabetes, while Novo Nordisk does the same for semaglutide as Ozempic.) The results have not yet been peer-reviewed
Whether patients progress in diabetic retinopathy or not, I would rather we potentially ameliorate their macrovascular risk of cardiovascular and cerebrovascular diseases, instead of worrying about microvascular, eye-related risks that we can manage appropriately with current modalities. New Indication, New Patients
After 21 days at room temperature, unused medication should be discarded even if the pen still contains solution